Silence Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Silence Therapeutics generated cash of -$39,350,000, which is more than the previous year. Cash used in financing activities reached the amount of $25,155,000 last year. Net change in cash is therefore -$785,000.
Cash Flow
| 2014 | -9.45M | -201K | 10.84M |
|---|---|---|---|
| 2015 | -8.25M | 4.32M | 39.15M |
| 2016 | -10.06M | -4.67M | -101K |
| 2017 | -9.59M | 13.01M | 48K |
| 2018 | -16.76M | -4.83M | 341K |
| 2019 | 1.72M | -15.01M | 5.27M |
| 2020 | -10.77M | 9.61M | 15.42M |
| 2021 | 6.80M | 8.67M | 30.71M |
| 2022 | -45.45M | -16.54M | 43.04M |
| 2023 | -39.35M | 16.43M | 25.15M |
SLN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 54.81M | 73.53M | 27.44M | 13.51M | 21.49M | 42.74M | 39.01M | 51.90M | 16.85M | 15.89M |
Operating activities | ||||||||||
Net income | -50.31M | -47.36M | -45.85M | -36.04M | -22.87M | -20.52M | -3.77M | -10.36M | -9.42M | -11.98M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 498K | 482K | 427K | 496K | 482K | 399K | 433K | 310K | 182K | 332K |
Stock-based compensation expense | 13.05M | 10.25M | 8.63M | 4.39M | 584K | 0 | 638K | 475K | 777K | 1.12M |
| Deferred income tax benefit | 13.05M | 10.25M | 8.63M | 4.39M | 584K | 0 | 638K | 475K | 777K | 1.12M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 314K | -584K | 27.48M | -29.30M | -4K | 0 | 664K | 0 | -228K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -39.35M | -45.45M | 6.80M | -10.77M | 1.72M | -16.76M | -9.59M | -10.06M | -8.25M | -9.45M |
Investing activities | ||||||||||
Purchases Of Investments | -20.66M | -16.12M | 10M | -40.04M | -15M | -5M | -4.92M | -4.29M | 0 | 0 |
Investments In Property Plant And Equipment | -45K | -440K | -1.33M | -514K | -9K | -188K | -173K | -537K | -850K | -338K |
Acquisitions Net | 0 | 0 | -10M | 40.71M | 0 | -58K | -13.21M | 0 | 0 | 0 |
Cash generated by investing activities | 16.43M | -16.54M | 8.67M | 9.61M | -15.01M | -4.83M | 13.01M | -4.67M | 4.32M | -201K |
Financing activities | ||||||||||
Common Stock Issued | 25.32M | 43.23M | 30.92M | 15.83M | 5.27M | 341K | 48K | 0 | 39.15M | 10.84M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -101K | 0 | 0 |
Repayments of term debt | -174K | -190K | -211K | -402K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 25.15M | 43.04M | 30.71M | 15.42M | 5.27M | 341K | 48K | -101K | 39.15M | 10.84M |
Net Change In Cash | -785K | -18.72M | 46.08M | 13.93M | -7.97M | -21.25M | 3.73M | -12.89M | 35.05M | 967K |
Cash at end of period | 54.03M | 54.81M | 73.53M | 27.44M | 13.51M | 21.49M | 42.74M | 39.01M | 51.90M | 16.85M |
| Data source | Data source | Data source | Data source |